• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上调的 RFC2 预测肝细胞癌的不良进展。

Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma.

机构信息

Department of Interventional Radiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600, Yishan Road, Xuhui District, Shanghai, 200233, China.

Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China.

出版信息

Hereditas. 2021 May 22;158(1):17. doi: 10.1186/s41065-021-00179-9.

DOI:10.1186/s41065-021-00179-9
PMID:34022962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141224/
Abstract

BACKGROUND

Replication factor C (RFC) is closely related to tumor progression and metastasis. However, the functional significance of RFC2 in hepatocellular carcinoma remains unclear.

MATERIALS AND METHODS

In order to solve this problem, the expression of RFC2 in liver cancer patients was analyzed through ONCOMINE, UALCAN, Human Protein Atlas. Survival analysis was conducted using Kaplan-Meier plotter and GEPIA. GO and KEGG enrichment analyses were carried out. The protein-protein interaction (PPI) network was performed through Metascape. Western blotting, cell counting kit-8 and transwell assay were used to detect the effect of RFC2 on cell proliferation and migration.

RESULTS

The transcription and protein level of RFC2 in HCC were overexpressed, which was significantly related to the clinical individual cancer stage and pathological tumor grade of HCC patients. In addition, in patients with liver cancer, higher RFC2 expression was found to be significantly correlated with shorter OS and DFS. Furthermore, the function of RFC2 in liver cancer was DNA replication, and its main mechanism was the phase transition of the cell cycle. Biological experiments demonstrated that knockdown of RFC2 reduced the proliferation and migration of HCC cells.

CONCLUSION

RFC2 might promote the development of liver cancer, which might be achieved by regulating cell cycle and DNA replication. It could be used as a novel biomarker for the prognosis of liver cancer.

摘要

背景

复制因子 C(RFC)与肿瘤的进展和转移密切相关。然而,RFC2 在肝细胞癌中的功能意义尚不清楚。

材料与方法

为了解决这个问题,我们通过 ONCOMINE、UALCAN、Human Protein Atlas 分析了肝癌患者中 RFC2 的表达。通过 Kaplan-Meier plotter 和 GEPIA 进行生存分析。进行 GO 和 KEGG 富集分析。通过 Metascape 进行蛋白质-蛋白质相互作用(PPI)网络分析。使用细胞计数试剂盒-8 和 Transwell 测定法检测 RFC2 对细胞增殖和迁移的影响。

结果

HCC 中 RFC2 的转录和蛋白水平过表达,与 HCC 患者的临床个体癌症分期和病理肿瘤分级显著相关。此外,在肝癌患者中,较高的 RFC2 表达与较短的 OS 和 DFS 显著相关。此外,RFC2 在肝癌中的功能是 DNA 复制,其主要机制是细胞周期的相变。生物学实验表明,敲低 RFC2 可降低 HCC 细胞的增殖和迁移。

结论

RFC2 可能通过调节细胞周期和 DNA 复制促进肝癌的发展,它可以作为肝癌预后的新型生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/b3a3c90dacde/41065_2021_179_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/6cc88b0f8c2e/41065_2021_179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/712d7b99939b/41065_2021_179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/e80c41b7fe72/41065_2021_179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/9853b04afb3c/41065_2021_179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/06166687f644/41065_2021_179_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/b3a3c90dacde/41065_2021_179_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/6cc88b0f8c2e/41065_2021_179_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/712d7b99939b/41065_2021_179_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/e80c41b7fe72/41065_2021_179_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/9853b04afb3c/41065_2021_179_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/06166687f644/41065_2021_179_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e1bd/8141224/b3a3c90dacde/41065_2021_179_Fig6_HTML.jpg

相似文献

1
Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma.上调的 RFC2 预测肝细胞癌的不良进展。
Hereditas. 2021 May 22;158(1):17. doi: 10.1186/s41065-021-00179-9.
2
Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.GNAZ 过表达预测肝癌不良预后,并促进 G0/G1 细胞周期进程。
Gene. 2022 Jan 10;807:145964. doi: 10.1016/j.gene.2021.145964. Epub 2021 Sep 14.
3
Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.E2F 转录因子 8(E2F8)在肝细胞癌结局中的致癌作用:综合生物信息学报告。
Biosci Rep. 2020 Feb 28;40(2). doi: 10.1042/BSR20193212.
4
Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.免疫浸润相关血清淀粉样蛋白 A1 预测肝细胞癌预后良好。
World J Gastroenterol. 2020 Sep 21;26(35):5287-5301. doi: 10.3748/wjg.v26.i35.5287.
5
Exploration of Prognostic Biomarkers among Replication Factor C Family in the Hepatocellular Carcinoma.肝细胞癌中复制因子C家族预后生物标志物的探索
Evol Bioinform Online. 2021 Feb 12;17:1176934321994109. doi: 10.1177/1176934321994109. eCollection 2021.
6
RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas.RFC2:一种与弥漫性低级别神经胶质瘤免疫特征相关的预后生物标志物。
Sci Rep. 2022 Feb 24;12(1):3122. doi: 10.1038/s41598-022-06197-5.
7
Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.肝细胞癌中 COMMD 蛋白家族的表达、预后价值和免疫浸润活性的转录分析。
BMC Cancer. 2021 Sep 7;21(1):1001. doi: 10.1186/s12885-021-08699-3.
8
Oncogene Delta/Notch-Like EGF-Related Receptor Promotes Cell Proliferation, Invasion, and Migration in Hepatocellular Carcinoma and Predicts a Poor Prognosis.原癌基因 Delta/Notch 样表皮生长因子受体促进肝癌细胞的增殖、侵袭和迁移,并预示不良预后。
Cancer Biother Radiopharm. 2018 Nov;33(9):380-386. doi: 10.1089/cbr.2018.2460. Epub 2018 Sep 20.
9
LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.基于体外实验、数据挖掘和RT-qPCR分析,长链非编码RNA NEAT1促进肝细胞癌恶化
Cell Physiol Biochem. 2018;48(2):540-555. doi: 10.1159/000491811. Epub 2018 Jul 18.
10
LncRNA SBF2-AS1 promotes hepatocellular carcinoma metastasis by regulating EMT and predicts unfavorable prognosis.长链非编码 RNA SBF2-AS1 通过调控 EMT 促进肝癌转移,并预测不良预后。
Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6333-6341. doi: 10.26355/eurrev_201810_16044.

引用本文的文献

1
Identification of expression profiles and prognostic value of RFCs in colorectal cancer.鉴定 RFCs 在结直肠癌中的表达谱和预后价值。
Sci Rep. 2024 Mar 19;14(1):6607. doi: 10.1038/s41598-024-56361-2.
2
Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer.鉴定 DNA 损伤反应相关基因作为去势抵抗性前列腺癌的生物标志物。
Sci Rep. 2023 Nov 10;13(1):19602. doi: 10.1038/s41598-023-46651-6.
3
RFC2 promotes aerobic glycolysis and progression of colorectal cancer.RFC2 促进有氧糖酵解和结直肠癌的进展。

本文引用的文献

1
Xanthohumol regulates miR-4749-5p-inhibited RFC2 signaling in enhancing temozolomide cytotoxicity to glioblastoma.黄腐酚通过调节 miR-4749-5p 抑制的 RFC2 信号增强替莫唑胺对神经胶质瘤的细胞毒性。
Life Sci. 2020 Aug 1;254:117807. doi: 10.1016/j.lfs.2020.117807. Epub 2020 May 16.
2
RFC2, a direct target of miR-744, modulates the cell cycle and promotes the proliferation of CRC cells.RFC2 是 miR-744 的直接靶标,调节细胞周期并促进 CRC 细胞的增殖。
J Cell Physiol. 2020 Nov;235(11):8319-8333. doi: 10.1002/jcp.29676. Epub 2020 Apr 2.
3
Next-generation characterization of the Cancer Cell Line Encyclopedia.
BMC Gastroenterol. 2023 Oct 11;23(1):353. doi: 10.1186/s12876-023-02984-0.
4
Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer.端粒相关基因风险模型用于预测肾癌的预后和药物治疗效果。
Front Immunol. 2022 Sep 16;13:975057. doi: 10.3389/fimmu.2022.975057. eCollection 2022.
5
Cell-cycle and apoptosis related and proteomics-based signaling pathways of human hepatoma Huh-7 cells treated by three currently used multi-RTK inhibitors.三种目前使用的多受体酪氨酸激酶抑制剂处理的人肝癌Huh-7细胞的细胞周期、凋亡相关及基于蛋白质组学的信号通路
Front Pharmacol. 2022 Aug 22;13:944893. doi: 10.3389/fphar.2022.944893. eCollection 2022.
6
CircCOL1A2 Sponges MiR-1286 to Promote Cell Invasion and Migration of Gastric Cancer by Elevating Expression of USP10 to Downregulate RFC2 Ubiquitination Level.环状 RNA COL1A2 通过海绵吸附 miR-1286 促进胃癌细胞侵袭和迁移,通过上调 USP10 降低 RFC2 泛素化水平。
J Microbiol Biotechnol. 2022 Jul 28;32(7):938-948. doi: 10.4014/jmb.2112.12044. Epub 2022 May 11.
7
Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma.RFC 家族基因在人类肉瘤中的表达、预后意义及免疫浸润的综合分析。
Aging (Albany NY). 2022 Apr 29;14(8):3705-3719. doi: 10.18632/aging.204039.
8
RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas.RFC2:一种与弥漫性低级别神经胶质瘤免疫特征相关的预后生物标志物。
Sci Rep. 2022 Feb 24;12(1):3122. doi: 10.1038/s41598-022-06197-5.
下一代癌症细胞系百科全书的特征描述。
Nature. 2019 May;569(7757):503-508. doi: 10.1038/s41586-019-1186-3. Epub 2019 May 8.
4
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.Metascape 为系统水平数据集的分析提供了面向生物学家的资源。
Nat Commun. 2019 Apr 3;10(1):1523. doi: 10.1038/s41467-019-09234-6.
5
Multifaceted regulation and functions of replication factor C family in human cancers.复制因子C家族在人类癌症中的多方面调控及功能
Am J Cancer Res. 2018 Aug 1;8(8):1343-1355. eCollection 2018.
6
Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.使用独立数据集的表达数据验证 miRNA 在肝细胞癌中的预后能力。
Sci Rep. 2018 Jun 15;8(1):9227. doi: 10.1038/s41598-018-27521-y.
7
MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.MCM 家族在 HCC 中的作用:MCM6 预示着不良的肿瘤特征和预后不良,并促进 S/G2 细胞周期进程。
BMC Cancer. 2018 Feb 20;18(1):200. doi: 10.1186/s12885-018-4056-8.
8
Gene expression profiling, pathway analysis and subtype classification reveal molecular heterogeneity in hepatocellular carcinoma and suggest subtype specific therapeutic targets.基因表达谱分析、通路分析和亚型分类揭示了肝细胞癌中的分子异质性,并提示了亚型特异性治疗靶点。
Cancer Genet. 2017 Oct;216-217:37-51. doi: 10.1016/j.cancergen.2017.06.002. Epub 2017 Jul 8.
9
A pathology atlas of the human cancer transcriptome.人类癌症转录组病理学图谱。
Science. 2017 Aug 18;357(6352). doi: 10.1126/science.aan2507.
10
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.UALCAN:一个促进肿瘤亚组基因表达和生存分析的平台。
Neoplasia. 2017 Aug;19(8):649-658. doi: 10.1016/j.neo.2017.05.002. Epub 2017 Jul 18.